Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients.
Čerina D, Matković V, Katić K, Belac Lovasić I, Šeparović R, Canjko I, Jakšić B, Petrić-Miše B, Bajić Ž, Boban M, Vrdoljak E. Čerina D, et al. Among authors: canjko i. J Oncol. 2021 Aug 5;2021:2815623. doi: 10.1155/2021/2815623. eCollection 2021. J Oncol. 2021. PMID: 34394349 Free PMC article.
Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice.
Čerina D, Matković V, Katić K, Lovasić IB, Šeparović R, Canjko I, Jakšić B, Fröbe A, Pleština S, Bajić Ž, Vrdoljak E. Čerina D, et al. Among authors: canjko i. Pathol Oncol Res. 2021 Sep 27;27:1609963. doi: 10.3389/pore.2021.1609963. eCollection 2021. Pathol Oncol Res. 2021. PMID: 34646088 Free PMC article.
The Impact of Pentraxin 3 Serum Levels and Angiotensin-Converting Enzyme Polymorphism on Pulmonary Infiltrates and Mortality in COVID-19 Patients.
Krivdić Dupan Z, Periša V, Suver Stević M, Mihalj M, Tolušić Levak M, Guljaš S, Salha T, Loinjak D, Kos M, Šapina M, Canjko I, Šambić Penc M, Štefančić M, Nešković N. Krivdić Dupan Z, et al. Among authors: canjko i. Biomedicines. 2024 Jul 20;12(7):1618. doi: 10.3390/biomedicines12071618. Biomedicines. 2024. PMID: 39062191 Free PMC article.
Real-world data on efficacy and safety of pembrolizumab in the first-line treatment of metastatic lung cancer in patients with PD-L1 expression >0% - a single center experience.
Cvijić T, Canjko I, Tomaš I, Kralik K, Perić L, Kotromanović D, Krivdić Dupan Z, Kovač Peić A, Mimica S. Cvijić T, et al. Among authors: canjko i. Eur Rev Med Pharmacol Sci. 2023 Oct;27(19):9213-9225. doi: 10.26355/eurrev_202310_33949. Eur Rev Med Pharmacol Sci. 2023. PMID: 37843335 Free article.
The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia.
Čerina D, Krpina K, Jakopović M, Dedić Plavetić N, Seiwerth F, Tomić S, Radić J, Belac Lovasić I, Canjko I, Boban M, Samaržija M, Vrdoljak E. Čerina D, et al. Among authors: canjko i. Cancers (Basel). 2023 Jun 28;15(13):3395. doi: 10.3390/cancers15133395. Cancers (Basel). 2023. PMID: 37444505 Free PMC article.